RDInvesting Provides Investors with Free In-Depth Equity Reports on BRCD, RVBD, VRSK and XRAY


Follow this company

Companies Mentioned

NASDAQ:BRCD / NASDAQ:RVBD / NASDAQ:VRSK / NASDAQ:XRAY
12/12/2013 [ACCESSWIRE]

Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.

Brocade Communications Systems, Inc. (NASDAQ: BRCD) shares declined 2.20 percent to close at $8.43a share Wednesday. The stock traded between $8.43 and $8.59 on volume of 4.94 million shares traded. Analysts at Citigroup have recently initiated coverage on the company with a "sell" rating. Shares of Brocade have gained approximately 58.0 percent year-to-date.

Find out more about Brocade including full access to the free equity report at:     
www.RDInvesting.com/BRCD

Riverbed Technology, Inc. (NASDAQ: RVBD) shares gained 0.24 percent to close at $16.95 a share Wednesday. The stock traded between $16.89 and $17.44 on volume of 1.56 million shares traded. Analysts at Citigroup have recently initiated coverage on the company with a "buy" rating. Shares of Riverbed Technology have fallen approximately 13.0 percent year-to-date.

Find out more about Riverbed Technology including full access to the free equity report at:     
www.RDInvesting.com/RVBD

Verisk Analytics, Inc. (NASDAQ: VRSK) shares declined 2.46 percent to close at $64.60 a share Wednesday. The stock traded between $64.56 and $65.91 on volume of 1.0 million shares traded. Analysts at Credit Suisse have recently initiated coverage on the company with a "neutral" rating. Shares of Verisk Analytics have gained approximately 27.0 percent year-to-date.

Find out more about Verisk Analytics including full access to the free equity report at:       
www.RDInvesting.com/VRSK

DENTSPLY International Inc. (NASDAQ: XRAY) shares increased 0.87 percent to close at $48.49 a share Wednesday. The stock traded between $48.36 and $50.99 on volume of 2.01 million shares traded. Analysts at Goldman Sachs have recently upgraded the company’s rating to "buy" from "neutral". Shares of DENTSPLY International have gained approximately 16.0 percent year-to-date.

Find out more about DENTSPLY International including full access to the free equity report at:       
www.RDInvesting.com/XRAY

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.

Contact:            
Research Driven Investing          
info@rdinvesting.com

COMMENTS

Leave a comment...
 * 

Your Name
 *